Notify me when Lynwood Capital Management Inc. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| KZIA | Kazia Therapeutics Limited | Ordinary Shares, no par value per share | 5.4% | $2,107,941,734 | 307,998,500 | Lynwood Capital Management Inc. | 15 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|